survivin在涎腺腺样囊性癌组织中表达及意义的Meta分析

佘杨杨; 张敏; 农晓琳

doi:10.13201/j.issn.1001-1781.2017.12.008

survivin在涎腺腺样囊性癌组织中表达及意义的Meta分析

- 1广西医科大学口腔医学院口腔颌面外科(南宁, 530021);
- 2 北京大学口腔医学院修复科
基金项目:
国家自然科学基金项目 (No:81360404)

广西自然科学基金面上项目 (No:2013GXNSFAA019231)

广西研究生教育创新计划项目 (No:201010598RY10)

广西高等教育本科教学改革工程立项项目 (No:2016JGA161)

详细信息

通讯作者: 农晓琳,E-mail:xnong@gxmu.edu.cn

中图分类号: R739.8

收稿日期: 2017-03-17

The expression and clinical significance of survivin in salivary gland adenoid cystic carcinoma:a Meta analysis

- 1 Department of Oral and Maxillofacial Surgery, College of Stomatology, Guangxi Medical University, Nanning, 530021, China;
- 2 Department of Prosthodontics, College of Stomatology, Peking University

More Information

Corresponding author: NONG Xiaolin, E-mail: xnong@gxmu.edu.cn

Received Date: 17 March 2017

摘要

摘要: 目的:系统评价survivin的表达与涎腺腺样囊性癌(SACC)的临床病理特征之间的相关性。方法:计算机检索PubMed、Embase、Cochrane Library、web of science、OVID、Springerlink、中国学术期刊全文数据库(CNKI)、中国生物医学数据库(CBM)、万方、重庆维普等数据库。根据各研究间的异质性,采用固定或随机效应模型合并比值比(ORs)和相应的95%可信区间(CIs),分析survivin表达与SACC的关联。结果:共纳入10个病例对照研究,包括367例SACC患者及124例正常对照。Meta分析结果显示:survivin在SACC组织中高表达(OR=38.26,95% CI:17.37~84.29,P<0.01),还与病理分型(OR=0.3,95% CI:0.17~0.55,P<0.01)、临床分期(OR=0.23,95% CI:0.13~0.42,P<0.01)以及淋巴结转移(OR=3.7,95% CI:1.82~7.56,P<0.01)有关,差异有统计学意义。结论:survivin的表达可能与SACC临床病理特征相关,但受纳入文献数量及质量的影响,尚需累积大样本高质量的研究来进一步证实。
- 涎腺腺样囊性癌 /
- survivin /
- Meta分析
Abstract: Objective: This Meta-analysis was performed to explore the association between survivin expression and clinical pathological features of salivary gland adenoid cystic carcinoma(SACC).Method: Literature was searched in some databases such as PubMed,Embase,Cochrane Library,web of science, OVID, Springerlink,CNKI,CBM,Wanfang and CQVIP.The pooled odds ratios(ORs) and 95% confidence intervals(95% CIs) were estimated to determine the correlation between survivin expression and SACC using a fixed or random effects model according to heterogeneity.Result: A total of ten studies with 367 SACC patients and 124 normal control subjects were included in this Meta-analysis.The results showed that survivin was overexpressed in SACC tissues(OR=38.26, 95% CI:17.37-84.29, P<0.01).It also revealed significant correlations between survivin expression and pathological types(OR=0.3, 95% CI:0.17-0.55, P<0.01),advanced tumor clinical stages(OR=0.23, 95% CI: 0.13-0.42, P<0.01) and lymph node metastasis(OR=3.7, 95% CI:1.82-7.56, P<0.01).Conclusion: The current study demonstrated that survivin expression may be associated with the clinical pathological features of SACC.However, due to the influence of the quantity and quality of the included literature, additional high quality of studies with larger sample sizes are needed to confirm our findings.
- salivary gland adenoid cystic carcinoma /
- survivin /
- Meta analysis

HTML全文

参考文献(27)

[1]	VEKONY H, YLSTRA B, WILTING S M, et al.DNA copy number gains at loci of growth factors and their receptors in salivary gland adenoid cystic carcinoma[J].Clin Cancer Res, 2007, 13:3133-3139.
[2]	LAURIE S A, HO A L, FURY M G, et al.Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands:a systematic review[J].Lancet Oncol, 2011, 12:815-824.
[3]	COCA-PELAZ A, RODRIGO J P, BRADLEY P J, et al.Adenoid cystic carcinoma of the head and neck——An update[J].Oral Oncol, 2015, 51:652-661.
[4]	PERSSON M, ANDRN Y, MARK J, et al.Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck[J].Proc Natl Acad Sci, 2009, 106:18740-18744.
[5]	RETTIG E M, TALBOT C C Jr, SAUSEN M, et al.Whole-genome sequencing of salivary gland adenoid cystic carcinoma[J].Cancer Prev Res (Phila), 2016, 9:265-274.
[6]	LLOYD S, YU J B, WILSON L D, et al.Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapy[J].Am J Clin Oncol, 2011, 34:76-81.
[7]	LLADSER A, SANHUEZA C, KIESSLING R, et al.Is survivin the potential Achilles'heel of cancer[J]?Adv Cancer Res, 2011, 111:1-37.
[8]	肖胤, 杨军, 肖林, 等.Survivin基因在人涎腺腺样囊性癌中的表达[J].临床口腔医学杂志, 2007, 23 (4):209-211.
[9]	冯建国.Survivin和bFGF在人涎腺腺样囊性癌组织中的表达及意义[D].山西医科大学, 2008.
[10]	李海峰.COX-2及survivin在涎腺腺样囊性癌中的表达研究[J].中国误诊学杂志, 2009, 9 (12):2817-2818.
[11]	王言, 张斌, 于涛, 等.涎腺腺样囊性癌组织中survivin、livin的表达变化及意义[J].山东医药, 2010, 50 (42):44-45.
[12]	刘敏, 李萍, 兰显国, 等.Survivin和VEGF在涎腺腺样囊性癌中的表达及临床意义[J].重庆医学, 2010, 39 (10):1231-1232.
[13]	史建洁, 李大海, 王阳阳.涎腺腺样囊性癌组织中survivin、COX-2的表达变化及意义[J].山东医药, 2011, 51 (50):100-101.
[14]	李腾宇, 石娜, 王旭霞, 等.Survivin及COX-2在涎腺腺样囊性癌中的表达研究[J].口腔医学研究, 2013, 29 (4):363-366.
[15]	王雪峰.Survivin及P53在唾液腺腺样囊性癌中表达的研究[D].佳木斯大学, 2014.
[16]	闫大勇.Survivin基因在涎腺腺样囊性癌中的表达意义[J].中国实用医刊, 2015, 42 (12):31-32.
[17]	刘通.SOX2和Survivin在涎腺腺样囊性癌中的表达及意义[D].西南医科大学, 2016.
[18]	ALTIERI D C.Targeting survivin in cancer[J].Cancer Lett, 2013, 332:225-228.
[19]	LIANG D, HU X, JIN Y, et al.Survivin protein expression is involved in the progression of non-small cell lung cancer in Asians:a meta-analysis[J].BMC Cancer, 2016, 16:276-276.
[20]	JAMIESON N B, CARTER C R, MCKAY C J, et al.Tissue biomarkers for prognosis in pancreatic ductal adenocarcinoma:a systematic review and meta-analysis[J].Clin Cancer Res, 2011, 17:3316-3331.
[21]	PU Z, WANG Q, XIE H, et al.Clinical pathological and prognostic significance of survivin expression in renal cell carcinoma:a meta-analysis[J].Oncotarget, 2017, 8:19825-19833.
[22]	YAMAMOTO T, TANIGAWA N.The role of survivin as a new target of diagnosis and treatment in human cancer[J].Med Electron Microsc, 2001, 34:207-212.
[23]	ALTIERI D C.New wirings in the survivin networks[J].Oncogene, 2008, 27:6276-6284.
[24]	FERNNDEZ J G, RODRGUEZ D A, VALENZUELA M, et al.Survivin expression promotes VEGF-induced tumor angiogenesis via PI3K/Akt enhanced β-catenin/Tcf-Lef dependent transcription[J].Mol Cancer, 2014, 13:209-209.
[25]	KO Y H, ROH S Y, WON H S, et al.Prognostic significance of nuclear survivin expression in resected adenoid cystic carcinomaof the head and neck[J].Head Neck Oncol, 2010, 2:30-30.
[26]	WANG Y F, MA S R, WANG W M, et al.Inhibition of survivin reduces HIF-1α, TGF-β1 and TFE3 in salivary adenoid cystic carcinoma[J].PLoS One, 2014, 9:e114051.
[27]	WANG Y F, ZHANG W, HE K F, et al.Induction of autophagy-dependent cell death by the survivin suppressant YM155 in salivary adenoid cystic carcinoma[J].Apoptosis, 2014, 19:748-748.